BRIEF-Cadila Healthcare says Zydus gets final USFDA approval for diflunisal tablets

Last Updated: Tue, Jun 20, 2017 11:00 hrs

June 20 (Reuters) - Cadila Healthcare Ltd:

* Says Zydus gets final approval from USFDA for diflunisal tablets

* Drug is a nonsteroidal anti-inflammatory drug; will be produced at group's formulations manufacturing facility at Baddi Source text: (http://bit.ly/2sNemKR) Further company coverage:

More from Sify: